Did not become law. It stopped in the Senate's Health Care Committee on July 7, 2017. The 2017 session has ended.
2017 Regular Session
Senate Bill 818
Requires health benefit plan that covers opioid analgesic drug products to cover abuse-deterrent opioid analgesic drug products, at no greater cost to insured than other preferred drugs under plan, and specifies other requirements regarding coverage.
What it does
The synopsis the Legislative Assembly published with the bill.
Requires health benefit plan that covers opioid analgesic drug products to cover abuse-deterrent opioid analgesic drug products, at no greater cost to insured than other preferred drugs under plan, and specifies other requirements regarding coverage.
Sponsors
Who carried the bill in each chamber, and who signed on. Each name leads to the member's page.
Its course
February 16 to July 7, 2017, on one scale. In the top row each mark is a day something happened; taller marks are busier days.
Each committee stop sits inside its chamber.
Every action3 actions on 3 days
In the SenateFeb 16 to Jul 7 · stopped141 days
Waiting for a committeeFeb 16 to Feb 171 day
Health CareFeb 17 to Jul 7 · stopped140 days
Text
Each version as the Legislative Assembly printed it.
l9n doesn't hold this bill's text yet.
What happened
In l9n's words, one line for each step. Every action as the Legislative Assembly published it is below.
In the Senate Feb 16 – Jul 7
- Feb 16Introduced
- Feb 17Sent to Health Care
- Jul 7Died when the session ended
All 3 actions, as published
- Feb 16Introduction and first reading. Referred to President's desk.Senate
- Feb 17Referred to Health Care.Senate
- Jul 7In committee upon adjournment.Senate